Chemistry, Manufacturing & Controls
Energy-Efficient Crystallization: Pioneering Sustainable Methods for Active Pharmaceutical Ingredients
Low-energy crystallization techniques provide a clear pathway toward reducing environmental impact while maintaining high-quality standards for APIs.
Assessing Sustainability: A Deep Dive into Life Cycle Analysis in Green Chemical Processes
The future of green chemistry will not be defined solely by individual reaction efficiencies or material substitutions but by a systems-level understanding of environmental impact.
Enzymatic Alchemy: Biocatalysis Transforming Chemical Manufacturing
As the world grapples with the dual challenges of environmental degradation and resource scarcity, biocatalysis offers a beacon of hope.
Catalysts: Pioneering Energy-Efficient Chemical Reactions
As industries and researchers work together to integrate these advancements into practical applications, catalysts are poised to transform chemical manufacturing, energy production, and environmental conservation.
Harnessing Nature’s Bounty: Renewable Feedstocks in Modern Chemical Processes
As the chemical industry continues to embrace sustainability, the utilization of renewable feedstocks will play a central role in shaping a resilient and eco-friendly future.
Mastering Precision: Biopharma PEG’s Monodispersed PEGs Revolutionize Pharmaceutical Innovation
Biopharma PEG announces a groundbreaking array of monodispersed PEGs to propel the pharma industry into a new era.
Revolutionizing Diabetes Therapeutics: Huateng Pharma Unveils Cutting-Edge Anti-Diabetes Intermediates
Huateng Pharma has unveiled a suite of advanced anti-diabetes intermediates, featuring compounds intricately designed to target diabetes with unprecedented precision.
Bora Health and Sunway Biotech Merger: A Gateway to Innovations in Nutraceuticals
The merger between Bora Health and Sunway Biotech marks the dawn of a transformative era in nutraceutical innovation.
Sai Life Sciences Ltd: Leveraging Chemistry for Accelerated BioPharma Drug Discovery
From its inception, SAI has prioritized the development of core capabilities in chemistry.
FDA Approves Precision BioSciences, Inc.’s CMC Strat for Late-Stage Azer-cel Development
FDA feedback indicates that Precision Biosciences’Â shared CMC plans are compliant with Agency expectations.
Novel Hyangnam Bioplant Valued at $117.9M as Daewoong Bio Enters CDMO Business
With 146 billion won, Daewoong Bio intends to enter the contract development and manufacturing organization (CDMO) market.